Live price temporarily unavailable.
Sonendo (SONX) is a Health Care company. Latest news and coverage below.
| FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $23.4M | $33.2M | $41.7M | $43.9M | $33.2M |
| Growth (year over year) | — | +42.2% | +25.5% | +5.3% | −24.3% |
| Gross profit | $3.88M | $8.34M | $10.5M | $4.67M | $11.8M |
| Gross margin | 16.6% | 25.1% | 25.2% | 10.6% | 35.7% |
| Operating income | −$42.8M | −$44.4M | −$58.2M | −$59.3M | −$29.4M |
| Operating margin | −183.3% | −133.8% | −139.7% | −135.1% | −88.5% |
| Net income | −$46.7M | −$48.5M | −$57.0M | −$60.9M | −$28.0M |
| Net margin | −199.8% | −146.1% | −137.0% | −138.9% | −84.4% |
| EPS (diluted) | −$39.02 | −$8.52 | −$1.27 | −$129.63 | −$59.03 |
| Balance sheet | |||||
| Cash and equivalents | $51.7M | $84.6M | $17.7M | $14.0M | $10.2M |
| Total assets | $76.1M | $115.5M | $137.3M | $78.2M | $31.3M |
| Total liabilities | $48.7M | $43.4M | $55.3M | $49.7M | $26.1M |
| Long-term debt | — | $26.5M | $36.7M | $12.5M | $3.64M |
| Shareholders' equity | −$253.9M | $72.1M | $82.0M | $28.4M | $5.19M |
| Cash flow | |||||
| Operating cash flow | −$38.5M | −$48.6M | −$61.1M | −$46.1M | −$24.7M |
| Capital expenditure | $916.0K | $638.0K | $1.36M | $929.0K | $161.0K |
| Free cash flow | −$39.5M | −$49.2M | −$62.4M | −$47.0M | −$24.8M |
| Q1 FY23Mar 2023 | Q2 FY23Jun 2023 | Q3 FY23Sep 2023 | Q4 FY23†Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $10.7M | $11.0M | $10.4M | $11.7M | $7.05M | $8.31M | $8.04M | $9.80M |
| Growth (year over year) | +18.7% | +4.7% | +5.7% | −4.4% | −34.3% | −24.7% | −22.8% | −16.2% |
| Gross profit | $1.98M | −$485.0K | $884.0K | $2.29M | $2.00M | $3.12M | $3.31M | $3.42M |
| Gross margin | 18.4% | −4.4% | 8.5% | 19.6% | 28.4% | 37.5% | 41.2% | 34.8% |
| Operating income | −$15.1M | −$17.4M | −$16.6M | −$10.3M | −$10.2M | −$6.69M | −$6.79M | −$5.64M |
| Operating margin | −140.5% | −157.2% | −159.2% | −87.9% | −145.4% | −80.4% | −84.5% | −57.5% |
| Net income | −$15.4M | −$17.7M | −$17.0M | −$10.9M | −$6.76M | −$7.37M | −$7.54M | −$6.37M |
| Net margin | −143.3% | −160.2% | −163.2% | −93.0% | −96.0% | −88.6% | −93.8% | −65.0% |
| EPS (diluted) | −$0.16 | −$0.19 | −$36.02 | −$93.26 | −$0.07 | −$0.08 | −$15.77 | −$43.11 |
| Balance sheet | ||||||||
| Cash and equivalents | $12.6M | $12.6M | $12.1M | $14.0M | $18.6M | $15.7M | $13.1M | $10.2M |
| Total assets | $123.9M | $104.1M | $88.3M | $78.2M | $56.8M | $46.3M | $38.1M | $31.3M |
| Total liabilities | $55.3M | $51.1M | $50.5M | $49.7M | $32.2M | $28.4M | $27.2M | $26.1M |
| Long-term debt | $36.9M | $37.0M | $37.2M | $12.5M | $10.9M | $8.51M | $6.08M | $3.64M |
| Shareholders' equity | $68.6M | $53.0M | $37.8M | $28.4M | $24.5M | $17.9M | $11.0M | $5.19M |
| Cash flow | ||||||||
| Operating cash flow | −$17.0M | −$9.37M | −$10.2M | −$9.51M | −$10.7M | −$6.72M | −$4.31M | −$2.93M |
| Capital expenditure | $210.0K | $417.0K | $216.0K | $86.0K | $146.0K | $15.0K | $0 | $0 |
| Free cash flow | −$17.2M | −$9.78M | −$10.4M | −$9.59M | −$10.8M | −$6.73M | −$4.31M | −$2.93M |
From Sonendo's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
No recent news mentioning Sonendo in our feed yet.